MELISSA MAYBURY: Open Payments
NPI 1710344981 · GRAVETTE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 19 payments from 7 companies in 2025. Trend: 2023 $549 · 2024 $2,255 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $232 |
| Janssen Pharmaceuticals, Inc | 6 | $216 |
| ABBVIE INC. | 5 | $137 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Auvelity, SPRAVATO, VRAYLAR, AUSTEDO XR, COBENFY, CAPLYTA, HETLIOZ, FANAPT.
Industry payments across AR — which companies pay providers there.
